Treatment of acquired immune deficiency syndrome (AIDS)related pneumonitis with foscarnet: A double-blind placebo controlled study
- 1 January 1990
- journal article
- clinical trial
- Published by Elsevier in Journal of Infection
- Vol. 20 (1), 41-50
- https://doi.org/10.1016/s0163-4453(90)92302-2
Abstract
No abstract availableThis publication has 10 references indexed in Scilit:
- DECLINING LEVELS OF HIV P24 ANTIGEN IN SERUM DURING TREATMENT WITH FOSCARNETThe Lancet, 1988
- Failure in generating hemopoietic stem cells is the primary cause of death from cytomegalovirus disease in the immunocompromised host.The Journal of Experimental Medicine, 1988
- IS CYTOMEGALOVIRUS INTERSTITIAL PNEUMONITIS IN TRANSPLANT RECIPIENTS AN IMMUNOPATHOLOGICAL CONDITION?The Lancet, 1987
- Treatment of cytomegalovirus pneumonitis with foscarnet (trisodium phosphonoformate) in patients with AIDSJournal of Medical Virology, 1987
- Use of Ganciclovir to Treat Serious Cytomegalovirus Infections in Patients with AIDSThe Journal of Infectious Diseases, 1987
- Pharmacokinetics, safety and preliminary clinical experiences using foscarnet in the treatment of cytomegalovirus infections in bone marrow and renal transplant recipientsJournal of Antimicrobial Chemotherapy, 1986
- RAPID DIAGNOSIS OF CYTOMEGALOVIRUS INFECTION IN IMMUNOCOMPROMISED PATIENTS BY DETECTION OF EARLY ANTIGEN FLUORESCENT FOCIThe Lancet, 1984
- Effect of 9-(1,3-dihydroxy-2-propoxymethyl)guanine on human cytomegalovirus replication in vitroAntimicrobial Agents and Chemotherapy, 1983
- Cytomegalovirus Infections in Homosexual MenAnnals of Internal Medicine, 1983
- Antiviral effects of phosphonoformate (PFA, foscarnet sodium)Pharmacology & Therapeutics, 1982